title: Repeat revascularization is a faulty end point for clinical trials.
authors.forename: Dhruv S
authors.initials: DS
authors.lastname: Kazi
authors.forename: Mark A
authors.initials: MA
authors.lastname: Hlatky
mesh_terms: D000787:Angina Pectoris / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male